Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Celularity ( (CELU) ) has issued an update.
On January 23, 2025, Celularity Inc. announced that its securities purchase agreement with an institutional investor expired due to non-receipt of the subscription amount, resulting in the cancellation of its planned private placement for common stock and warrants. This development may impact the company’s fundraising efforts and its financial strategy moving forward.
More about Celularity
Celularity Inc. operates in the biotechnology industry, focusing on developing cell therapies from placental-derived cells to treat cancer, infectious, and degenerative diseases.
YTD Price Performance: 4.55%
Average Trading Volume: 1,166,772
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.71M
See more data about CELU stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue